Breaking News on Global Pharmaceutical Technology & Manufacturing

Anti-malaria drug casts light on cancer therapy

25-Sep-2017 - A treatment combining anti-malaria drug artemisinin and light-sensitive molecules could kill cancer cells and hinder tumour growth, say researchers.

Dry powder development: Vectura’s BI alternative backed by Pulmatrix

19-Sep-2017 - Vectura has advanced plans to develop a dry powder inhaler to treat patients with chronic obstructive pulmonary disease (COPD) for the US market.

Puracap's Wuhan site passes US FDA inspection prompted by ANDA

19-Sep-2017 - US regulators are satisfied a soft gelatin capsule plant in Wuhan, China is up to code according to Puracap Pharmaceutical LLC.


Single shot in 'tiny coffee cups’ could deliver multiple vaccines, MIT

18-Sep-2017 - 3-D microparticles which degrade at differing rates in the body could allow multiple doses of drugs or vaccines to be administered in a single injection, say MIT researchers.

BMS inks $105m deal to access Halozyme drug delivery tech

14-Sep-2017 - Bristol-Myers Squibb will also make up to $160m in milestone payments for each candidate developed using Halozyme Therapeutics’ large-volume biologics delivery platform.

Oramed looking for commercialisation partner for oral insulin in US

06-Sep-2017 - Oramed is eying up commercial partnerships for its oral insulin candidate following a positive meeting with the US FDA to discuss an appropriate approval pathway.

Catalent looking to parenteral dosage form capability for future expansion

29-Aug-2017 - Catalent says it will focus its M&A strategy to fill the injectables capability gap in its CDMO offering.

AZ confirms Macclesfield plan but says “wait to see” Brexit strategy unchanged

29-Aug-2017 - AstraZeneca has said it will wait to see how Brexit negotiations progress before deciding whether to make mid-to-large scale manufacturing investments in the UK.

Indian Gov outlines plan to favour drugs containing locally made APIs

29-Aug-2017 - Price controls and procurement programmes would favour drugs containing locally-made APIs under a Government proposal designed to reduce India's reliance on imported ingredients and intermediates.

Lonza expands Swiss drug product site, adds 50 jobs

25-Aug-2017 - Lonza will feed demand for its drug quality testing and formulation capabilities through an expansion at its Drug Product Services site in Basel, Switzerland.

AstraZeneca ups its mRNA stake through €25m Ethris deal

22-Aug-2017 - AstraZeneca has entered a five-year collaboration to develop therapies for respiratory diseases based on Ethris’ messenger RNA (mRNA) technology.

Aerie Pharma to use DSM polymers to develop eye drug delivery tech

16-Aug-2017 - Aerie Pharmaceuticals Inc will use a DSM polymer technology to develop an implant to deliver AR-13154, its wet AMD drug candidate.

BASF outlines plans for $50m Mumbai R&D campus

16-Aug-2017 - BASF has confirmed the innovation campus it is setting up in India will employ 300 people and cater for multiple markets across Asia and elsewhere.

Corning collaborates for Merck & Co and Pfizer-tested vials

14-Aug-2017 - Corning has penned separate collaboration agreements with Italy-based Stevanato Group and Germany-headquartered Gerresheimer to supply glass packaging for injectable drugs. 

Alexion ends Moderna mRNA pact

28-Jul-2017 - Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

News in brief

Mitsubishi Tanabe to pay $1.1bn for Parkinson's drug formulator Neuroderm

25-Jul-2017 - Mitsubishi Tanabe Pharma has agreed to pay $1.1bn (€943m) to acquire Parkinson’s disease focused formulation and drug-device developer Neuroderm Ltd.

Glenmark selects Cyndea to make gel capsule drugs

19-Jul-2017 - Cyndea Pharma and Glenmark Pharmaceuticals have partnered to make generic soft-gelatin capsule products for multiple markets.

Pfizer hires Catalent to make smaller format Advil using Optigel tech

18-Jul-2017 - Pfizer Inc. has awarded Catalent Pharma Solutions the long-term manufacturing contract for a smaller version of its over-the-counter (OTC) painkiller Advil (ibuprofen). 

Elite halts trials of reformulated SequestOx after BE data falls short

10-Jul-2017 - Elite Pharmaceuticals has halted trials of its reformulated opioid painkiller SequestOx (naltrexone and oxycodone hydrochloride) after disappointing bioequivalence data from a study testing the drug in combination with a high fat meal.

Nanoparticle delivery tech targets rare lung disease

10-Jul-2017 - Researchers at London, UK-based Imperial College are developing a technology to transport drugs directly to the lungs of pulmonary arterial hypertension (PAH) patients.

Pump up the volume: Cellnovo adding insulin device line in Romania

04-Jul-2017 - French technology firm Cellnovo has selected Flex Ltd to build a production line in Romania, to manufacture insulin cartridges for its diabetes management system.

Microneedle patch stable, painless and simple say researchers

29-Jun-2017 - The team behind a microneedle patch designed to administer influenza vaccines say it has increased thermostability compared to needle and syringe immunisation methods.

Opiant has new Narcan nasal spray patent listed in US FDA orange book

29-Jun-2017 - Opiant Pharmaceuticals says it has strengthened its IP position for the emergency opioid overdose treatment Narcan nasal spray.

Pfizer starts work on Missouri biotherapeutics R&D hub

28-Jun-2017 - Pfizer is building a $200m (€179m) R&D centre in Chesterfield, Missouri at which it will consolidate biotherapeutics process development operations in the region.

Lonza’s $5.5bn Capsugel takeover cleared by regulators

27-Jun-2017 - Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...